Relevate_Logo_CMYK (small).jpg
Relevate Power, Leading Hydropower Redeveloper, Announces Two Strategic Hires
May 09, 2024 09:34 ET | Relevate Power
Relevate Power, Leading Hydropower Redeveloper, Announces Two Strategic Hires
Cronos-WM-Black_Logo 2 (2).jpg
Cronos Group Reports 2024 First Quarter Results
May 09, 2024 07:30 ET | Cronos Group Inc.
Industry-leading balance sheet with $855 million in cash and cash equivalents Net revenue in Q1 2024 increased by 30% year-over-year to $25.3 million Spinach® was top-3 in retail...
Bekaert_logo_pos_RGB.jpg
Bekaert: Algemene Vergaderingen van Aandeelhouders
May 08, 2024 09:06 ET | Bekaert
Algemene Vergaderingen van Aandeelhouders -           Goedkeuring bruto dividend van € 1,80 -           Goedkeuring voorgestelde herbenoemingen Op woensdag 8 mei 2024 heeft de Gewone Algemene...
Bekaert_logo_pos_RGB.jpg
Bekaert: General Meetings of Shareholders
May 08, 2024 09:06 ET | Bekaert
General Meetings of Shareholders -           Approval of a gross dividend of € 1.80-           Approval of the proposed reappointments On Wednesday 8 May 2024, Bekaert’s Annual General Meeting...
PR368-v2
EY Announces Gene Sheridan of Navitas Semiconductor as an Entrepreneur Of The Year® 2024 Greater Los Angeles Award Finalist
May 08, 2024 08:30 ET | Navitas Semiconductor Corporation
LOS ANGELES, May 08, 2024 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) today announced that Gene Sheridan, CEO and co-founder of Navitas Semiconductor (Nasdaq:NVTS) was named an Entrepreneur Of...
eyepoint logo.png
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
May 08, 2024 07:00 ET | EyePoint Pharmaceuticals, Inc.
– Company on track to initiate the Phase 3 LUGANO pivotal non-inferiority trial of DURAVYU™ in wet AMD in 2H 2024 – – $299 million of cash and investments on March 31, 2024, with cash runway through...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
May 08, 2024 07:00 ET | Faruqi & Faruqi LLP
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ocugen, Inc. (“Ocugen” or the “Company”)...
EY Announces Vadim V
EY Announces Vadim Vladimirskiy of Nerdio as an Entrepreneur Of The Year® 2024 Midwest Award Finalist
May 07, 2024 10:00 ET | Nerdio
CHICAGO, May 07, 2024 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) today announced that Vadim Vladimirskiy, CEO and co-founder of Nerdio, was named an Entrepreneur Of The Year® 2024 Midwest...
eyepoint logo.png
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy
May 06, 2024 07:00 ET | EyePoint Pharmaceuticals, Inc.
– DURAVYU demonstrates stable or improved disease severity with reduced rates of NPDR progression at nine months – – DURAVYU continues to demonstrate favorable safety and tolerability profile with no...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUE
May 04, 2024 17:04 ET | The Rosen Law Firm PA
NEW YORK, May 04, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of bluebird bio...